Effect of evobrutinib, a Bruton's tyrosine kinase inhibitor, on patient-reported vitality and mental health in patients with relapsing multiple sclerosis in a Phase 2 trial
Multiple Sclerosis and Related Disorders(2023)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要